Header

BUY LIFE SCIENCE REPORTS

PharmaVision offers a comprehensive choice of high quality, insightful reports which identify key trends, future innovations, and growth opportunities. Our reports cover the life science arena including pharmaceuticals, healthcare, diagnostics, drug delivery, emerging R&D technologies and consumer nutrition.

FEATURED REPORT

Featured Reports Icon

Global Pharmaceuticals, Biotechnology & Life Sciences

Actelion acquired by Johnson & Johnson for $30 billion ($280 per share in cash). The acquisition will enable J&J to gain access to Actelion's PAH franchise which includes Opsumit, Uptravi, Tracleer, Veletri and Ventavis. It will also lead to a spin out of Actelion's drug discovery operations and early-stage clinical development assets into a newly created Swiss biopharmaceutical company R&D NewCo.

FREE WHITE PAPER

Free White Paper

Factors Currently Diving Pharmaceutical Growth in the Middle East

During the last decade the pharmaceutical industry has been looking towards the emerging economies to expand its global footprint and drive future growth. This white paper focuses on the potential opportunities for investment in the Middle East, particularly with respect to Bahrain, Saudi Arabia and the United Arab Emirates.

EVENTS 2017

Events Icon

Biosimilars Congress India 2017

8th Aug 2017 - 9th Aug 2017